APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nasal Decongestant

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nasal Decongestant Market Outlook and Growth Opportunities 2026

19 December 2025196 pages

Choose your research edition.

Industry ResearchNasal Decongestant Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nasal Decongestant Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Nasal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nasal Decongestant Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Nasal Decongestant Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Nasal Decongestant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nasal Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nasal Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nasal Decongestant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nasal Decongestant market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nasal Decongestant market include Abbott Laboratories, Glaxosmithkline, Bayer, Rugby Laboratories, Procter and Gamble, Patrick Parsons, Nidda Healthcare, Cipla and ADAPT Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nasal Decongestant market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nasal Decongestant and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nasal Decongestant sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nasal Decongestant market size, projected growth trends, production technologies, key applications, and end-use industries.

Nasal Decongestant Segment by Company

Abbott Laboratories

Glaxosmithkline

Bayer

Rugby Laboratories

Procter and Gamble

Patrick Parsons

Nidda Healthcare

Cipla

ADAPT Pharma

Nasal Decongestant Segment by Type

Nasal Strips

Capsule

Spray

Tablet

Nasal Decongestant Segment by Application

Nasal Allergies

Cold

Asthma

Nasal Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Nasal Decongestant status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nasal Decongestant market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nasal Decongestant significant trends, drivers, influence factors in global and regions.

6. To analyze Nasal Decongestant competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nasal Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nasal Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nasal Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nasal Decongestant market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nasal Decongestant industry.

Chapter 3: Detailed analysis of Nasal Decongestant manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nasal Decongestant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nasal Decongestant in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nasal Decongestant Industry Trends Table 2. Nasal Decongestant Industry Drivers Table 3. Nasal Decongestant Industry Opportunities and Challenges Table 4. Nasal Decongestant Industry Restraints Table 5. Global Nasal Decongestant Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nasal Decongestant Revenue Share by Company (2021-2026) Table 7. Global Nasal Decongestant Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nasal Decongestant Sales Volume Share by Company (2021-2026) Table 9. Global Nasal Decongestant Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nasal Decongestant Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nasal Decongestant Key Company Manufacturing Base & Headquarters Table 12. Global Nasal Decongestant Company, Product Type & Application Table 13. Global Nasal Decongestant Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nasal Decongestant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Strips Table 18. Significant Companies of Capsule Table 19. Significant Companies of Spray Table 20. Significant Companies of Tablet Table 21. Global Nasal Decongestant Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Nasal Decongestant Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Nasal Decongestant Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Nasal Decongestant Sales Volume Share by Type (2021-2026) Table 25. Global Nasal Decongestant Sales Volume Share by Type (2027-2032) Table 26. Global Nasal Decongestant Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Nasal Decongestant Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Nasal Decongestant Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Nasal Decongestant Sales Value Share by Type (2021-2026) Table 30. Global Nasal Decongestant Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Nasal Allergies Table 32. Significant Companies of Cold Table 33. Significant Companies of Asthma Table 34. Global Nasal Decongestant Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Nasal Decongestant Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Nasal Decongestant Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Nasal Decongestant Sales Volume Share by Application (2021-2026) Table 38. Global Nasal Decongestant Sales Volume Share by Application (2027-2032) Table 39. Global Nasal Decongestant Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nasal Decongestant Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nasal Decongestant Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nasal Decongestant Sales Value Share by Application (2021-2026) Table 43. Global Nasal Decongestant Sales Value Share by Application (2027-2032) Table 44. Global Nasal Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Nasal Decongestant Sales by Region (2021-2026) & (K Units) Table 46. Global Nasal Decongestant Sales Market Share by Region (2021-2026) Table 47. Global Nasal Decongestant Sales by Region (2027-2032) & (K Units) Table 48. Global Nasal Decongestant Sales Market Share by Region (2027-2032) Table 49. Global Nasal Decongestant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nasal Decongestant Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nasal Decongestant Sales Value Share by Region (2021-2026) Table 52. Global Nasal Decongestant Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nasal Decongestant Sales Value Share by Region (2027-2032) Table 54. Global Nasal Decongestant Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Nasal Decongestant Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Nasal Decongestant Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Nasal Decongestant Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nasal Decongestant Sales by Country (2021-2026) & (K Units) Table 59. Global Nasal Decongestant Sales Market Share by Country (2021-2026) Table 60. Global Nasal Decongestant Sales by Country (2027-2032) & (K Units) Table 61. Global Nasal Decongestant Sales Market Share by Country (2027-2032) Table 62. Global Nasal Decongestant Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nasal Decongestant Sales Value Market Share by Country (2021-2026) Table 64. Global Nasal Decongestant Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nasal Decongestant Sales Value Market Share by Country (2027-2032) Table 66. Abbott Laboratories Company Information Table 67. Abbott Laboratories Business Overview Table 68. Abbott Laboratories Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Abbott Laboratories Nasal Decongestant Product Portfolio Table 70. Abbott Laboratories Recent Development Table 71. Glaxosmithkline Company Information Table 72. Glaxosmithkline Business Overview Table 73. Glaxosmithkline Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Glaxosmithkline Nasal Decongestant Product Portfolio Table 75. Glaxosmithkline Recent Development Table 76. Bayer Company Information Table 77. Bayer Business Overview Table 78. Bayer Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Bayer Nasal Decongestant Product Portfolio Table 80. Bayer Recent Development Table 81. Rugby Laboratories Company Information Table 82. Rugby Laboratories Business Overview Table 83. Rugby Laboratories Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Rugby Laboratories Nasal Decongestant Product Portfolio Table 85. Rugby Laboratories Recent Development Table 86. Procter and Gamble Company Information Table 87. Procter and Gamble Business Overview Table 88. Procter and Gamble Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Procter and Gamble Nasal Decongestant Product Portfolio Table 90. Procter and Gamble Recent Development Table 91. Patrick Parsons Company Information Table 92. Patrick Parsons Business Overview Table 93. Patrick Parsons Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Patrick Parsons Nasal Decongestant Product Portfolio Table 95. Patrick Parsons Recent Development Table 96. Nidda Healthcare Company Information Table 97. Nidda Healthcare Business Overview Table 98. Nidda Healthcare Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Nidda Healthcare Nasal Decongestant Product Portfolio Table 100. Nidda Healthcare Recent Development Table 101. Cipla Company Information Table 102. Cipla Business Overview Table 103. Cipla Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Cipla Nasal Decongestant Product Portfolio Table 105. Cipla Recent Development Table 106. ADAPT Pharma Company Information Table 107. ADAPT Pharma Business Overview Table 108. ADAPT Pharma Nasal Decongestant Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. ADAPT Pharma Nasal Decongestant Product Portfolio Table 110. ADAPT Pharma Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Nasal Decongestant Distributors List Table 114. Nasal Decongestant Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Nasal Decongestant Product Image Figure 2. Global Nasal Decongestant Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nasal Decongestant Sales (2021-2032) & (K Units) Figure 5. Global Nasal Decongestant Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nasal Decongestant Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Strips Image Figure 10. Capsule Image Figure 11. Spray Image Figure 12. Tablet Image Figure 13. Global Nasal Decongestant Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Nasal Decongestant Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Nasal Decongestant Sales Volume Share by Type (2021-2032) Figure 16. Global Nasal Decongestant Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Nasal Decongestant Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Nasal Decongestant Sales Value Share by Type (2021-2032) Figure 19. Nasal Allergies Image Figure 20. Cold Image Figure 21. Asthma Image Figure 22. Global Nasal Decongestant Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Nasal Decongestant Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nasal Decongestant Sales Volume Share by Application (2021-2032) Figure 25. Global Nasal Decongestant Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nasal Decongestant Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nasal Decongestant Sales Value Share by Application (2021-2032) Figure 28. Global Nasal Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Nasal Decongestant Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nasal Decongestant Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nasal Decongestant Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nasal Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nasal Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nasal Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nasal Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nasal Decongestant Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nasal Decongestant Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nasal Decongestant Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nasal Decongestant Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nasal Decongestant Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nasal Decongestant Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nasal Decongestant Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Strips
  • Capsule
  • Spray
  • Tablet
Applications
  • Nasal Allergies
  • Cold
  • Asthma
Companies covered
  • Abbott Laboratories
  • Glaxosmithkline
  • Bayer
  • Rugby Laboratories
  • Procter and Gamble
  • Patrick Parsons
  • Nidda Healthcare
  • Cipla
  • ADAPT Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nasal Decongestant Sales Value (2021-2032)
  4. 1.2.2 Global Nasal Decongestant Sales Volume (2021-2032)
  5. 1.2.3 Global Nasal Decongestant Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nasal Decongestant Market Dynamics
  1. 2.1 Nasal Decongestant Industry Trends
  2. 2.2 Nasal Decongestant Industry Drivers
  3. 2.3 Nasal Decongestant Industry Opportunities and Challenges
  4. 2.4 Nasal Decongestant Industry Restraints
3 Nasal Decongestant Market by Company
  1. 3.1 Global Nasal Decongestant Company Revenue Ranking in 2025
  2. 3.2 Global Nasal Decongestant Revenue by Company (2021-2026)
  3. 3.3 Global Nasal Decongestant Sales Volume by Company (2021-2026)
  4. 3.4 Global Nasal Decongestant Average Price by Company (2021-2026)
  5. 3.5 Global Nasal Decongestant Company Ranking (2024-2026)
  6. 3.6 Global Nasal Decongestant Company Manufacturing Base and Headquarters
  7. 3.7 Global Nasal Decongestant Company Product Type and Application
  8. 3.8 Global Nasal Decongestant Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nasal Decongestant Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nasal Decongestant Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nasal Decongestant Market by Type
  1. 4.1 Nasal Decongestant Type Introduction
  2. 4.1.1 Nasal Strips
  3. 4.1.2 Capsule
  4. 4.1.3 Spray
  5. 4.1.4 Tablet
  6. 4.2 Global Nasal Decongestant Sales Volume by Type
  7. 4.2.1 Global Nasal Decongestant Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Nasal Decongestant Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Nasal Decongestant Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Nasal Decongestant Sales Value by Type
  11. 4.3.1 Global Nasal Decongestant Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Nasal Decongestant Sales Value by Type (2021-2032)
  13. 4.3.3 Global Nasal Decongestant Sales Value Share by Type (2021-2032)
5 Nasal Decongestant Market by Application
  1. 5.1 Nasal Decongestant Application Introduction
  2. 5.1.1 Nasal Allergies
  3. 5.1.2 Cold
  4. 5.1.3 Asthma
  5. 5.2 Global Nasal Decongestant Sales Volume by Application
  6. 5.2.1 Global Nasal Decongestant Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nasal Decongestant Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nasal Decongestant Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nasal Decongestant Sales Value by Application
  10. 5.3.1 Global Nasal Decongestant Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nasal Decongestant Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nasal Decongestant Sales Value Share by Application (2021-2032)
6 Nasal Decongestant Regional Sales and Value Analysis
  1. 6.1 Global Nasal Decongestant Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nasal Decongestant Sales by Region (2021-2032)
  3. 6.2.1 Global Nasal Decongestant Sales by Region: 2021-2026
  4. 6.2.2 Global Nasal Decongestant Sales by Region (2027-2032)
  5. 6.3 Global Nasal Decongestant Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nasal Decongestant Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nasal Decongestant Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nasal Decongestant Sales Value by Region (2027-2032)
  9. 6.5 Global Nasal Decongestant Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nasal Decongestant Sales Value (2021-2032)
  12. 6.6.2 North America Nasal Decongestant Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nasal Decongestant Sales Value (2021-2032)
  15. 6.7.2 Europe Nasal Decongestant Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nasal Decongestant Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nasal Decongestant Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nasal Decongestant Sales Value (2021-2032)
  21. 6.9.2 South America Nasal Decongestant Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nasal Decongestant Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nasal Decongestant Sales Value Share by Country, 2025 VS 2032
7 Nasal Decongestant Country-level Sales and Value Analysis
  1. 7.1 Global Nasal Decongestant Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nasal Decongestant Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nasal Decongestant Sales by Country (2021-2032)
  4. 7.3.1 Global Nasal Decongestant Sales by Country (2021-2026)
  5. 7.3.2 Global Nasal Decongestant Sales by Country (2027-2032)
  6. 7.4 Global Nasal Decongestant Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nasal Decongestant Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nasal Decongestant Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nasal Decongestant Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nasal Decongestant Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nasal Decongestant Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nasal Decongestant Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nasal Decongestant Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nasal Decongestant Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nasal Decongestant Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nasal Decongestant Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nasal Decongestant Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nasal Decongestant Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nasal Decongestant Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nasal Decongestant Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nasal Decongestant Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nasal Decongestant Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nasal Decongestant Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nasal Decongestant Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nasal Decongestant Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nasal Decongestant Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nasal Decongestant Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nasal Decongestant Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nasal Decongestant Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nasal Decongestant Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nasal Decongestant Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nasal Decongestant Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nasal Decongestant Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nasal Decongestant Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nasal Decongestant Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nasal Decongestant Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nasal Decongestant Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nasal Decongestant Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Nasal Decongestant Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 Glaxosmithkline
  8. 8.2.1 Glaxosmithkline Company Information
  9. 8.2.2 Glaxosmithkline Business Overview
  10. 8.2.3 Glaxosmithkline Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Glaxosmithkline Nasal Decongestant Product Portfolio
  12. 8.2.5 Glaxosmithkline Recent Developments
  13. 8.3 Bayer
  14. 8.3.1 Bayer Company Information
  15. 8.3.2 Bayer Business Overview
  16. 8.3.3 Bayer Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Bayer Nasal Decongestant Product Portfolio
  18. 8.3.5 Bayer Recent Developments
  19. 8.4 Rugby Laboratories
  20. 8.4.1 Rugby Laboratories Company Information
  21. 8.4.2 Rugby Laboratories Business Overview
  22. 8.4.3 Rugby Laboratories Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Rugby Laboratories Nasal Decongestant Product Portfolio
  24. 8.4.5 Rugby Laboratories Recent Developments
  25. 8.5 Procter and Gamble
  26. 8.5.1 Procter and Gamble Company Information
  27. 8.5.2 Procter and Gamble Business Overview
  28. 8.5.3 Procter and Gamble Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Procter and Gamble Nasal Decongestant Product Portfolio
  30. 8.5.5 Procter and Gamble Recent Developments
  31. 8.6 Patrick Parsons
  32. 8.6.1 Patrick Parsons Company Information
  33. 8.6.2 Patrick Parsons Business Overview
  34. 8.6.3 Patrick Parsons Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Patrick Parsons Nasal Decongestant Product Portfolio
  36. 8.6.5 Patrick Parsons Recent Developments
  37. 8.7 Nidda Healthcare
  38. 8.7.1 Nidda Healthcare Company Information
  39. 8.7.2 Nidda Healthcare Business Overview
  40. 8.7.3 Nidda Healthcare Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nidda Healthcare Nasal Decongestant Product Portfolio
  42. 8.7.5 Nidda Healthcare Recent Developments
  43. 8.8 Cipla
  44. 8.8.1 Cipla Company Information
  45. 8.8.2 Cipla Business Overview
  46. 8.8.3 Cipla Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Cipla Nasal Decongestant Product Portfolio
  48. 8.8.5 Cipla Recent Developments
  49. 8.9 ADAPT Pharma
  50. 8.9.1 ADAPT Pharma Company Information
  51. 8.9.2 ADAPT Pharma Business Overview
  52. 8.9.3 ADAPT Pharma Nasal Decongestant Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 ADAPT Pharma Nasal Decongestant Product Portfolio
  54. 8.9.5 ADAPT Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nasal Decongestant Value Chain Analysis
  2. 9.1.1 Nasal Decongestant Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nasal Decongestant Sales Mode & Process
  6. 9.2 Nasal Decongestant Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nasal Decongestant Distributors
  9. 9.2.3 Nasal Decongestant Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst